Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2006;114:e523-e524
doi: 10.1161/CIRCULATIONAHA.106.626317
This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Que, Y.-A.
Right arrow Articles by Liaudet, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Que, Y.-A.
Right arrow Articles by Liaudet, L.
Related Collections
Right arrow Imaging
Right arrow Valvular heart disease

(Circulation. 2006;114:e523-e524.)
© 2006 American Heart Association, Inc.


Images in Cardiovascular Medicine

Rapid Resolution of Massive Lung Abscesses Complicating Tricuspid-Valve Endocarditis

Yok-Ai Que, MD, PhD; Olivier Muller, MD, PhD; Lucas Liaudet, MD

From the Department of Intensive Care Medicine (Y.-A.Q., L.L.) and the Service of Cardiology (O.M.), University Hospital, Lausanne, Switzerland.

Corresponding to Professor Lucas Liaudet, MD, Department of Intensive Care Medicine, BH 10-982, University Hospital, 1011 Lausanne, Switzerland. E-mail Lucas.Liaudet{at}chuv.ch

A 33-year-old female intravenous drug abuser presented with fever and acute respiratory failure requiring mechanical ventilation. Chest x-ray and a thoracic computed tomographic scan revealed multiple nodular lesions with cavitation (Figure 1). A transesophageal echocardiogram disclosed a tricuspid-valve vegetation (Figure 2), and blood cultures were positive for Staphylococcus aureus. A diagnosis of tricuspid-valve endocarditis with septic pulmonary emboli (SPE) was made. Antibiotherapy with intravenous flucloxacillin and gentamicin induced a spectacular regression of the lung abscesses, allowing weaning from mechanical ventilation after 8 days and discharge from the hospital after 4 weeks (Figure 1).


Figure 1178255
View larger version (120K):
[in this window]
[in a new window]
 
Figure 1. Repeated computed tomographic scans of the chest from apex to base showing massive, bilateral, nodular lesions with cavitation on admission (A, B, and C). Spectacular improvement of the lesions under appropriate antibiotic therapy was noted after 14 days (D, E, and F), and almost complete resolution was noted after 4 weeks (G, H, and I).


Figure 2178255
View larger version (31K):
[in this window]
[in a new window]
 
Figure 2. Transesophageal echocardiography (4-chamber view) showing a large mobile mass attached to the atrial surface of the anterior leaflet of the tricuspid valve.

Infective endocarditis is a serious complication of intravenous drug abuse, with a reported mortality of 5% to 10%.1 In a recent retrospective series of 493 cases of infective endocarditis, 220 (44.6%) occurred in intravenous drug users. The tricuspid valve was most frequently affected (88% of cases), and S aureus was the most frequently encountered pathogen.2 SPE are relatively common in this setting. Intravenous drug users comprised 78% of a cohort of 60 patients with SPE reported in 1978,3 and tricuspid endocarditis was the embolic source in 53% of the cases. Although SPE may be particularly severe and life-threatening, appropriate antibiotherapy may result in rapid resolution of the lung abscesses, as indicated here, and thus such a complication should not be considered an indication for valve surgery in the setting of tricuspid endocarditis.


*    Disclosure
up arrowTop
*Disclosure
down arrowReferences
 
Dr Liaudet is supported by the Swiss National Fund for Scientific Research (Grant Nr PP00B-68882/1). The other authors have no potential conflicts of interest to disclose.


*    References
up arrowTop
up arrowDisclosure
*References
 
1. Moreillon P, Que YA. Infective endocarditis. Lancet. 2004; 363: 139–149.[CrossRef][Medline] [Order article via Infotrieve]

2. Martin-Davila P, Navas E, Fortun J, Moya JL, Cobo J, Pintado V, Quereda C, Jimenez-Mena M, Moreno S. Analysis of mortality and risk factors associated with native valve endocarditis in drug users: the importance of vegetation size. Am Heart J. 2005; 150: 1099–1106.[CrossRef][Medline] [Order article via Infotrieve]

3. MacMillan JC, Milstein SH, Samson PC. Clinical spectrum of septic pulmonary embolism and infarction. J Thorac Cardiovasc Surg. 1978; 75: 670–679.[Abstract]





This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Que, Y.-A.
Right arrow Articles by Liaudet, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Que, Y.-A.
Right arrow Articles by Liaudet, L.
Related Collections
Right arrow Imaging
Right arrow Valvular heart disease